Shares of Merck are climbing on Tuesday after the pharmaceuticals company reported higher profits in its first quarter. The second-largest drugmaker in the U.S. earned an adjusted 88 cents a share which came in 9 cents higher than analysts expected. Profitability was boosted over the quarter after research spending was cut 20-percent to $1.5 billion. For fiscal 2014, management guided for adjusted earnings of $3.35 to $3.53 a share, inline with expectations for $3.44 a share.
Subscribe to TheStreetTV on YouTube:
For more content from TheStreet visit:
Check out all our videos:
Follow TheStreet on Twitter:
Like TheStreet on Facebook:
Follow TheStreet on LinkedIn:
Follow TheStreet on Google+:
source
